TransMedics

US · TMDX #2536 by market cap Listed 2019

81.07 +0.79 +0.98%

Live - 5344 symbols - heartbeat 30s ago · 2026-10-08 07:00

Pre-market 81.15 +0.10%

After-hours 81.07 0.00%

Overnight 80.22 -1.05%

Market cap: 2.81B
P/E (TTM): 21.00
P/B: 5.43
EPS: 4.87
Div yield: 0.00%
52W pos: 22%

Reader sentiment Are you bullish or bearish on TMDX?

Anonymous reader poll. Unscientific, not investment advice.

About TransMedics

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Founded: 1998
CEO: Dr. Waleed H. Hassanein, M.D.
Employees: 898
Headquarters: Andover, Massachusetts, United States of America
Fiscal year end: 12-31
Website: transmedics.com

Company profile

Exchange: US
Symbol: TMDX
Market-cap rank: #2536
Listing date: 2019-05-02
Market cap: 2.81B
Float cap: 2.72B
Shares out: 34.68M
Float shares: 33.56M

Sectors & themes

Medical Devices Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 07:00:00 · For reference only, not investment advice and not tailored to your situation.